Insights

    Advancing the science and practice of sleep medicine through evidence-based insights and data-driven analysis.

    insights
    Filter
    filter
    Category
    Content type

    Early ID & risk stratification

    OSA underdiagnosis: A world of difference, a common challenge

    At World Sleep 2025, international experts shared firsthand insights on what's broken and what's working in global OSA diagnosis. Hear the discussion on tackling missed diagnosis, challenging outdated norms and building new models of care.

    View arrow

    Early ID & risk stratification

    Sleep: The too-often missing piece in cardiology

    Real-life experience from a cardiology practice.

    View arrow

    Early ID & risk stratification

    OSA in women: What are we doing wrong?

    Male-based models overlook how OSA presents in women. Phenotyping shows why severity scoring misses risk and delays effective care.

    View arrow

    Early ID & risk stratification

    Why COMISA needs strategic primary care education

    Dr. Sweetman shares how COMISA care can improve with strategic GP education, cross-specialty collaboration and increased CBT-I access.

    View arrow

    Early ID & risk stratification

    The Swedish OSA treatment matrix: Implementation lessons

    Professor Grote reflects on the clinical reception, implementation and impact of the Swedish OSA treatment matrix since its 2021 rollout.

    View arrow

    Early ID & risk stratification

    Symptoms and comorbidities in the Swedish treatment matrix

    Professor Grote explains how symptoms and comorbidities are evaluated within the context of the Swedish treatment matrix.

    View arrow

    Early ID & risk stratification

    Registries shaping sleep apnea care in Europe

    Professor Grote discusses the role of national and European registries in advancing sleep apnea care.

    View arrow

    Early ID & risk stratification

    Rethinking OSA screening and diagnosis in women

    Hear from Dr. Jonna Morris about diagnostic and screening blind spots surrounding women and OSA.

    View arrow

    Early ID & risk stratification

    Diagnostic blind spots: How OSA presents differently in women

    Dr. Jonna Morris explains how language and reporting patterns affect OSA presentation in women, and why many remain overlooked.

    View arrow

    Early ID & risk stratification

    What's next for the Baveno classification?

    Hear from Prof. Winfried Randerath about the adoption of the Baveno classification into clinical practice and the role of primary care in that.

    View arrow

    Early ID & risk stratification

    How the Baveno classification impacts key patient groups

    Hear from Prof. Winfried Randerath what impact the modified Baveno classification has for women, people with mild OSA and others.

    View arrow

    Early ID & risk stratification

    AHI's evolving role in the modified Baveno classification

    Hear from Prof. Winfried Randerath how and why AHI has been added to the modified Baveno classification and its impact on patients.

    View arrow

    Early ID & risk stratification

    Professor Winfried Randerath and the modified Baveno classification

    Hear from Prof. Winfried Randerath how the Baveno classification has been modified to more effectively categorize patients with sleep apnea.

    View arrow

    Early ID & risk stratification

    Beyond AHI: The search for more robust OSA diagnostic criteria

    AHI as the sole or primary OSA diagnostic criteria puts too many people at risk by preventing treatment for those who need it.

    View arrow

    Early ID & risk stratification

    How AHI came to be the standard diagnostic measure

    The AHI and OSA are deeply intertwined, but questions have been asked about AHI as a metric of OSA diagnosis and classification from the beginning.

    View arrow

    Early ID & risk stratification

    Beyond the stereotypes: Obstructive sleep apnea in women

    A growing body of research shows how gender biases and stereotypes of obstructive sleep apnea stand in the way of women receiving the help they need.

    View arrow

    Early ID & risk stratification

    How P4 medicine can improve diagnosis and treament of OSA

    Current approaches to OSA leave many struggling, often going undiagnosed and untreated. A P4 mindset can shift thinking to identify at-risk patients earlier.

    View arrow
    No result found
    scroll-to-top

    Privacy|Terms of use |©2026 Resmed|All rights reserved